HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives

HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives

Hepatitis C virus (HCV) infection is one of the most serious complications of transfusion therapy in the thalassemia and sickle cell disease (SCD) population before 1990; in fact, since 1990 serological tests were made available to detect infection in blood donors. The iron chelation therapy has imp...

Full description

Bibliographic Details
Main Authors: Laura Maffei, Francesco Sorrentino, Patrizia Caprari, Gloria Taliani, Sara Massimi, Roberta Risoluti, Stefano Materazzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Molecular Biosciences
Subjects:
hepatitis C
direct acting antivirals
thalassemia major
sickle cell disease
iron overload
transfusion
Online Access:https://www.frontiersin.org/article/10.3389/fmolb.2020.00007/full

Internet

https://www.frontiersin.org/article/10.3389/fmolb.2020.00007/full

Similar Items